pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea

BACKGROUND: Pyrazinamide (PZA) is among the first-line drugs for the treatment of tuberculosis. In vitro, it kills semidormant mycobacteria only at low pH. The purpose of this study was to compare PZA resistance with pyrazinamidase (PZase) activity and the genotype to better understand the molecular...

Cijeli opis

Bibliografski detalji

Izdano u:	BMC Infect Dis
Glavni autori:	Park, Soon Kew, Lee, Jung Yoo, Chang, Chulhun Ludgerus, Lee, Min Ki, Son, Han Chul, Kim, Cheol Min, Jang, Hyun Jung, Park, Hee Kyung, Jeong, Seok Hoon
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2001
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC33507/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11429043/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2334-1-4
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!